{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:57:15Z","timestamp":1790074635699,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17K19875"],"award-info":[{"award-number":["17K19875"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jpainsymman.2022.06.010","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T02:05:01Z","timestamp":1656381901000},"page":"e231-e234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Drug Choice for Hyperactive Delirium in Terminally-Ill Cancer Patients: A Nationwide Survey"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-9377","authenticated-orcid":false,"given":"Yoshinobu","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8614-8449","authenticated-orcid":false,"given":"Kiyofumi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8081-5979","authenticated-orcid":false,"given":"Keita","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi Shirado","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-4344","authenticated-orcid":false,"given":"Hiroyuki","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0001","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archinte.160.6.786","article-title":"Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study","volume":"160","author":"Lawlor","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0002","doi-asserted-by":"crossref","first-page":"iv143","DOI":"10.1093\/annonc\/mdy147","article-title":"Delirium in adult cancer patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Bush","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0003","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1634\/theoncologist.2018-0242","article-title":"Current pharmacotherapy does not improve severity of hypoactive delirium in patients with advanced cancer: pharmacological audit study of safety and efficacy in real world (Phase-R)","volume":"24","author":"Okuyama","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0004","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.genhosppsych.2020.09.001","article-title":"Safety and effectiveness of antipsychotic medication for delirium in patients with advanced cancer: a large-scale multicenter prospective observational study in real-world palliative care settings","volume":"67","author":"Maeda","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.sleep.2018.01.010","article-title":"Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials","volume":"45","author":"Yi","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0006","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1089\/jpm.2020.0610","article-title":"Low-dose trazodone for delirium in patients with cancer who received specialist palliative care: a multicenter prospective study","volume":"24","author":"Maeda","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","article-title":"Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial","volume":"177","author":"Agar","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0008","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1470-2045(20)30307-7","article-title":"Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial","volume":"21","author":"Hui","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0009","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1001\/jama.2017.11468","article-title":"Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial","volume":"318","author":"Hui","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jpainsymman.2022.06.010_bib0010","article-title":"A retrospective comparison of haloperidol and hydroxyzine combination therapy with haloperidol alone in the treatment of overactive delirium","author":"Sato","year":"2022","journal-title":"Support Care Cancer"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392422007862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392422007862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:21Z","timestamp":1760132121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392422007862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0885392422007862"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.06.010","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Choice for Hyperactive Delirium in Terminally-Ill Cancer Patients: A Nationwide Survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}